|
US6265401B1
(en)
|
1997-10-27 |
2001-07-24 |
Reddy-Cheminor, Inc. |
Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
WO1999016758A1
(en)
*
|
1997-10-27 |
1999-04-08 |
Dr. Reddy's Research Foundation |
Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
US6444816B1
(en)
|
1997-10-27 |
2002-09-03 |
Dr. Reddy's Research Foundation |
Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof
|
|
AU749505B2
(en)
*
|
1997-10-27 |
2002-06-27 |
Dr. Reddy's Laboratories Limited |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
|
US6369067B1
(en)
|
1997-10-27 |
2002-04-09 |
Dr. Reddy's Research Foundation |
Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
AU752059B2
(en)
|
1997-10-27 |
2002-09-05 |
Dr. Reddy's Laboratories Limited |
Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
|
WO1999019313A1
(en)
*
|
1997-10-27 |
1999-04-22 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
|
US6531596B1
(en)
|
1998-10-29 |
2003-03-11 |
Dr. Reddy's Laboratories Ltd. |
Process for the preparation of new antidiabetic agents
|
|
JP2002528535A
(en)
|
1998-10-29 |
2002-09-03 |
ドクター・レディーズ・リサーチ・ファウンデーション |
An improved method for producing new antidiabetic agents
|
|
US6972294B1
(en)
|
1999-04-20 |
2005-12-06 |
Novo Nordisk, A/S |
Compounds, their preparation and use
|
|
DK1206457T3
(en)
|
1999-08-27 |
2004-02-16 |
Lilly Co Eli |
Biaryl-oxa (thia) zole derivatives and their use as modulators PPAPs
|
|
CZ304346B6
(en)
*
|
2000-01-19 |
2014-03-19 |
Cadila Healthcare Ltd. |
Substituted pyrrole derivative exhibiting hypolipidemic and hypocholesteremic activity , process for its preparation and pharmaceutical composition containing thereof
|
|
US6555577B1
(en)
|
2000-01-28 |
2003-04-29 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
US6509374B2
(en)
|
2000-04-17 |
2003-01-21 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
US6559335B2
(en)
|
2000-09-22 |
2003-05-06 |
Dr. Reddy's Laboratories Limited |
Process for the preparation of 3-aryl-2-hydroxy propanoic acid
|
|
NZ529033A
(en)
|
2001-05-15 |
2005-06-24 |
F |
Carboxylic acid substituted oxazole derivatives for use as PPAR-alpha and -gamma activators in the treatment of diabetes
|
|
SE0101978D0
(en)
|
2001-06-01 |
2001-06-01 |
Astrazeneca Ab |
New compounds
|
|
WO2003006022A1
(en)
*
|
2001-07-09 |
2003-01-23 |
Dr. Reddy's Laboratories Ltd. |
Tetrahydroquinoline derivatives and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
US6987123B2
(en)
|
2001-07-26 |
2006-01-17 |
Cadila Healthcare Limited |
Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
|
|
US6869967B2
(en)
|
2001-07-30 |
2005-03-22 |
Novo Nordisk A/S |
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
|
|
US7067530B2
(en)
|
2001-07-30 |
2006-06-27 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
US7220877B2
(en)
|
2001-10-17 |
2007-05-22 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
US7015345B2
(en)
|
2002-02-21 |
2006-03-21 |
Asahi Kasei Pharma Corporation |
Propionic acid derivatives
|
|
ATE372990T1
(en)
|
2002-07-03 |
2007-09-15 |
Hoffmann La Roche |
OXAZOLE DERIVATIVES AND THE USE THEREOF AS INSULIN SENSITIZERS
|
|
BR0313946A
(en)
|
2002-08-30 |
2005-07-12 |
Hoffmann La Roche |
Compounds, process for the manufacture of these compounds, pharmaceutical compositions comprising them, methods for treating and / or preventing diseases that are modulated by ppara (alpha) and / or ppary agonists, use of the compounds and / or method
|
|
RU2296759C2
(en)
|
2002-09-12 |
2007-04-10 |
Ф.Хоффманн-Ля Рош Аг |
N-substituted 1h-indole-5-propionic acids, pharmaceutical composition containing these compounds and their using (variants)
|
|
ES2312819T3
(en)
|
2002-11-25 |
2009-03-01 |
F. Hoffmann-La Roche Ag |
DERIVATIVES OF INDOLILO.
|
|
US7816385B2
(en)
|
2002-12-20 |
2010-10-19 |
High Point Pharmaceuticals, Llc |
Dimeric dicarboxylic acid derivatives, their preparation and use
|
|
KR101733414B1
(en)
|
2011-01-31 |
2017-05-10 |
카딜라 핼쓰캐어 리미티드 |
Treatment for lipodystrophy
|
|
WO2014174524A1
(en)
|
2013-04-22 |
2014-10-30 |
Cadila Healthcare Limited |
A novel composition for nonalcoholic fatty liver disease (nafld)
|
|
MX2015016403A
(en)
|
2013-05-30 |
2016-04-11 |
Cadila Healthcare Ltd |
A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities.
|
|
TW201636015A
(en)
|
2013-07-05 |
2016-10-16 |
卡地拉保健有限公司 |
Synergistic compositions
|
|
IN2013MU02470A
(en)
|
2013-07-25 |
2015-06-26 |
Cadila Healthcare Ltd |
|
|
WO2015033357A2
(en)
|
2013-09-06 |
2015-03-12 |
Cadila Healthcare Limited |
An improved process for the preparation of pyrrole derivatives
|
|
WO2017064635A2
(en)
|
2015-10-14 |
2017-04-20 |
Cadila Healthcare Limited |
Pyrrole compound, compositions and process for preparation thereof
|
|
MX382765B
(en)
|
2016-12-09 |
2025-03-13 |
Zydus Lifesciences Ltd |
TREATMENT FOR PRIMARY BILIARY CHOLANGITIS.
|